EBNET MEDICAL GMBH – Trademark Portfolio
Entity Type: 03
EBNET MEDICAL GMBH holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include ROBUNULE. The owner is based in SCHWERIN.
AUGUST-BEBEL-STRAßE 26
SCHWERIN 19055 , DE
Showing of trademarks Trademarks
Trademark Classifications
EBNET MEDICAL GMBH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does EBNET MEDICAL GMBH have?
EBNET MEDICAL GMBH has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 2 cancelled.
What trademark classes does EBNET MEDICAL GMBH file in?
EBNET MEDICAL GMBH files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are EBNET MEDICAL GMBH's most well-known trademarks?
EBNET MEDICAL GMBH's registered trademark portfolio includes well-known marks such as ROBUNULE. These are among 1 currently registered trademark in the portfolio.
What is EBNET MEDICAL GMBH's trademark registration success rate?
EBNET MEDICAL GMBH has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.